Showing results (1-10 of 9,071) with videos related to
Sort By:
Pageof 908
Acta Materia Medica|August 20, 2025
PROTAC technology for prostate cancer treatmentZhen Wang, Dingpeng Zhang, Hiroyuki Inuzuka, et al.RSC Medicinal Chemistry|May 14, 2025
Proximity-induced membrane protein degradation for cancer therapiesDingpeng Zhang, Zhen Wang, Hiroyuki Inuzuka, et al.Journal of the American Chemical Society|April 11, 2025
USP28-Based Deubiquitinase-Targeting Chimeras for Cancer TreatmentZhen Wang, Chao Qian, Yan Xiong, et al.ACS Pharmacology & Translational Science|November 14, 2024
Targeted Degradation of Receptor-Interacting Protein Kinase 1 to Modulate the Necroptosis PathwayHiroyuki Inuzuka, Chao Qian, Yihang Qi, et al.Neoplasia (New York, N.Y.)|June 3, 2023
PRMT1 methylates METTL14 to modulate its oncogenic functionJingchao Wang, Zhen Wang, Hiroyuki Inuzuka, et al.Journal of the American Chemical Society|April 19, 2025
Harnessing the Deubiquitinase USP1 for Targeted Protein StabilizationChao Qian, Zhen Wang, Yan Xiong, et al.Journal of the American Chemical Society|September 29, 2023
Methylated Nucleotide-Based Proteolysis-Targeting Chimera Enables Targeted Degradation of Methyl-CpG-Binding Protein 2Zhen Wang, Jing Liu, Xing Qiu, et al.Journal of the American Chemical Society|March 12, 2024
Structurally Specific Z-DNA Proteolysis Targeting Chimera Enables Targeted Degradation of Adenosine Deaminase Acting on RNA 1Zhen Wang, Dingpeng Zhang, Xing Qiu, et al.Acta Materia Medica|March 2, 2022
The regulation of neuronal autophagy and cell survival by MCL1 in Alzheimer's diseaseAbdol-Hossein Rezaeian, Wenyi Wei, Hiroyuki InuzukaAdvances in Protein Chemistry and Structural Biology|April 15, 2023
Insights into the aberrant CDK4/6 signaling pathway as a therapeutic target in tumorigenesisAbdol-Hossein Rezaeian, Hiroyuki Inuzuka, Wenyi WeiPageof 908